New COVID-19 vaccine for fall should target JN.1 lineage, not variant, FDA panel

June 5, 2024

Current vaccines don’t provide as much protection against JN.1 and its several sub-variants that have been driving cases for months.

Current vaccines don’t provide as much protection against JN.1 and its several sub-variants that have been driving cases for months. USA TODAY – Breaking News and Latest News Today Read More

Written by:

Rate it